Actavis Group and Japan’s ASKA Pharmaceutical formally signed contracts recently establishing a new joint company called Actavis ASKA K.K. The new business will be headquartered in Tokyo. The joint company intends to enter the Japanese generic pharmaceutical market right away in April 2009. ASKA will hold a 55 percent stake in ... Read More...
generic drugs manufacturer
Entering the Irish market last week, Actavis plans to create up to 25 new local jobs over the next five years and to launch more than 120 generic drugs in Ireland, with the potential to save millions of euro off the country’s annual health bill. The new roles Actavis will create ... Read More...
Actavis, the international generic pharmaceutical company, has entered into an exclusive distribution agreement, for a number of generic products, with J&M Pharma, Co Ltd, a Korean owned and operated pharmaceutical company, headquartered in Seoul, Korea. The agreement is an important step in building Actavis’ presence in the Korean generics market. Actavis ... Read More...
Breaking the ground for a new solid oral dosage plant at Actavis’ current SOD site in Alathur, India. Gudbjorg Edda Eggertsdottir, deputy CEO and G. Shankar, Country Manager, Actavis India. Actavis has announced that three new construction projects are underway at Actavis in India. Actavis’ Deputy CEO, Guðbjörg Edda Eggertsdóttir recently ... Read More...